Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Biovector Therapeutics Signs Deals With Chiron, Bayer

March 24, 1999

Spinal Cord, Brain Injuries Targets Of New Program

March 24, 1999

Scotias Cancer Treatment Granted Fast-Track Status

March 24, 1999

Progens Antitumor Drug Positive; Plans Trials In U.S.

March 24, 1999

Other News To Note

March 24, 1999

Cantab Reports Earnings, Plans Phase II Studies

March 17, 1999

Other News To Note

March 17, 1999

Scientists Start Company Using Proteome Analysis

March 17, 1999

Synsorb Biotech Acquiring Oncolytics, Reovirus Drugs

March 17, 1999

European Parliament Backs Orphan Drug Development

March 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...